China Swine Vaccines Market to 2032
Overview
The China Swine Vaccines Market is expected to reach a 812.45 USD Million by 2032 and is projected to grow at a CAGR of 6.77% from 2025 to 2032.
Revenue, 2024 (USD Million)
481.85
Forecast, 2032 (USD Million)
812.45
CAGR, 2024 - 2032
6.77%
Report Coverage
China
China Swine Vaccines Market 2018-2032 USD Million
China Swine Vaccines Market, Key Findings (2025-2032)
Market Growth and Projections:
- Market Size (2024): 481.85 USD Million
- Projected Market Size (2032): 812.45 USD Million
- CAGR (2025-2032): 6.77%
Key Findings of China Swine Vaccines Market
- The China Swine Vaccines Market was valued at 481.85 USD Million in 2024.
- The China Swine Vaccines Market is likely to grow at a CAGR of 6.77% during the forecast period of 2024 to 2032.
- In 2024, the Largest segment Virus in Pathogen Segment accounted for the largest share of the market with a revenue of 319.37 USD Million
- The fastest growing segment Ingelvac in Product Segment grew Fastest with a CAGR of 9.98% during the forecast period from 2024 to 2032.
China Swine Vaccines Market Scope
China Swine Vaccines Market Segmentation & Scope
Product
- Clear The False Spirit
- Ruiyuanshu
- Refute
- Ruifute-Wang
- Shield
- Suigen
- Vepured
- Ruilan
- Progressis
- Coglapix
- Navet-Asfvac & Avac Asf Live
- Enteroporc Coli Ac
- Parvoruvax
- Ecoporc Shiga
- Salmoporc
- Hyogen
- Others
- Circovac
- Yuan Ke Xin
- Enradin
- Bioaftogen
- Enterisol
- Cirbloc M Hyo
- Prevacent
- Improvac
- Porcilis
- Ingelvac
Route of Administration
- Others
- Subcutaneous
- Intramuscular
Distribution Channel
- Others
- E-commerce Platforms
- Retail Pharmacies
- Hospitals and Clinics
Indication
- Others
- Glaesserella Parasuis
- Porcine Parovirus
- Porcine Pneumonia
- Foot-And-Mouth Disease (FMD)
- Swine Fever
- Porcine Circovirus Associated Disease (PCV/PCVD)
- Porcine Reproductive and Respiratory Syndrome (PRRS)
Pathogen
- Bacteria
- Virus
Technology
- Others
- Toxoid Vaccines
- Live Attenuated Vaccines
- Recombinant Vaccines
- Inactivated Vaccines
China Swine Vaccines Market Data Coverage Insights
| Study Period | 2024-2032 |
| Base Year | 2024 |
| Unit | Revenue in USD Million |
| Market Value in 2024 | 481.85 USD Million |
| Market Value in 2032 | 812.45 USD Million |
| CAGR (2025-2032) | 6.77% |
| Historic Data | 2016-2023 |
| Market Segments Covered | Product,Route of Administration,Distribution Channel,Indication,Pathogen,Technology |
Regional Insights:
-
Leading Market (2024-2032): China, leading in terms of revenue 481.85 USD Million in 2024
- Key Country: China, leading in terms of revenue with value of 481.85 USD Million in 2024.
Segments and Scope
-
China Swine Vaccines Market to 2032, By Product
- Ingelvac is the largest segment in China Swine Vaccines Market to 2032 with a revenue of 80.28 USD Million in the year 2024.
- Ingelvac is the Fastest growing segment in China Swine Vaccines Market to 2032 with a Growth rate of 9.98 % in forecast period 2025-2032.
-
China Swine Vaccines Market to 2032, By Route of Administration
- Intramuscular is the largest segment in China Swine Vaccines Market to 2032 with a revenue of 220.98 USD Million in the year 2024.
- Intramuscular is the Fastest growing segment in China Swine Vaccines Market to 2032 with a Growth rate of 7.42 % in forecast period 2025-2032.
-
China Swine Vaccines Market to 2032, By Distribution Channel
- Hospitals and Clinics is the largest segment in China Swine Vaccines Market to 2032 with a revenue of 171.88 USD Million in the year 2024.
- Hospitals and Clinics is the Fastest growing segment in China Swine Vaccines Market to 2032 with a Growth rate of 7.19 % in forecast period 2025-2032.
-
China Swine Vaccines Market to 2032, By Indication
- Porcine Reproductive and Respiratory Syndrome (PRRS) is the largest segment in China Swine Vaccines Market to 2032 with a revenue of 115.79 USD Million in the year 2024.
- Porcine Reproductive and Respiratory Syndrome (PRRS) is the Fastest growing segment in China Swine Vaccines Market to 2032 with a Growth rate of 8.42 % in forecast period 2025-2032.
-
China Swine Vaccines Market to 2032, By Pathogen
- Virus is the largest segment in China Swine Vaccines Market to 2032 with a revenue of 319.37 USD Million in the year 2024.
- Virus is the Fastest growing segment in China Swine Vaccines Market to 2032 with a Growth rate of 7.33 % in forecast period 2025-2032.
-
China Swine Vaccines Market to 2032, By Technology
- Inactivated Vaccines is the largest segment in China Swine Vaccines Market to 2032 with a revenue of 169.47 USD Million in the year 2024.
- Inactivated Vaccines is the Fastest growing segment in China Swine Vaccines Market to 2032 with a Growth rate of 7.37 % in forecast period 2025-2032.
China Swine Vaccines Market Company Share Analysis
| Company Name |
|
||
| Merck & Co., Inc. | |||
| Zoetis Services LLC | |||
| Boehringer Ingelheim International GmbH | |||
| Ceva | |||
| Jinyu Biotechnology Co., Ltd. | |||
China Swine Vaccines Market Geographical Sales Distribution, 2018-2032 USD Million
China Swine Vaccines Market Company Profiling
Industry Related Reports
Frequently Asked Questions
The China Swine Vaccines Market is segmented based on Segmentation Product,Route of Administration,Distribution Channel,Indication,Pathogen,Technology.
China Swine Vaccines Market was valued at USD 481.85(Revenue in USD Million) in 2024.
China Swine Vaccines Market is projected to grow at a CAGR of 6.77% during the forecast period of 2024 to 2032.
The Virus segment is expected to dominate the China Swine Vaccines Market, holding a largest market share of 319.37 USD Million in 2024
China Swine Vaccines Market Scope
China Swine Vaccines Market Segmentation & Scope
Product
- Clear The False Spirit
- Ruiyuanshu
- Refute
- Ruifute-Wang
- Shield
- Suigen
- Vepured
- Ruilan
- Progressis
- Coglapix
- Navet-Asfvac & Avac Asf Live
- Enteroporc Coli Ac
- Parvoruvax
- Ecoporc Shiga
- Salmoporc
- Hyogen
- Others
- Circovac
- Yuan Ke Xin
- Enradin
- Bioaftogen
- Enterisol
- Cirbloc M Hyo
- Prevacent
- Improvac
- Porcilis
- Ingelvac
Route of Administration
- Others
- Subcutaneous
- Intramuscular
Distribution Channel
- Others
- E-commerce Platforms
- Retail Pharmacies
- Hospitals and Clinics
Indication
- Others
- Glaesserella Parasuis
- Porcine Parovirus
- Porcine Pneumonia
- Foot-And-Mouth Disease (FMD)
- Swine Fever
- Porcine Circovirus Associated Disease (PCV/PCVD)
- Porcine Reproductive and Respiratory Syndrome (PRRS)
Pathogen
- Bacteria
- Virus
Technology
- Others
- Toxoid Vaccines
- Live Attenuated Vaccines
- Recombinant Vaccines
- Inactivated Vaccines
Frequently Asked Questions
The China Swine Vaccines Market is segmented based on Segmentation Product,Route of Administration,Distribution Channel,Indication,Pathogen,Technology.
China Swine Vaccines Market was valued at USD 481.85(Revenue in USD Million) in 2024.
China Swine Vaccines Market is projected to grow at a CAGR of 6.77% during the forecast period of 2024 to 2032.
The estimated market value of the China Swine Vaccines Market for final year is USD 812.45 (USD Million).
China Swine Vaccines Market Company Profiling
Frequently Asked Questions
The China Swine Vaccines Market is segmented based on Segmentation Product,Route of Administration,Distribution Channel,Indication,Pathogen,Technology.
China Swine Vaccines Market was valued at USD 481.85(Revenue in USD Million) in 2024.
China Swine Vaccines Market is projected to grow at a CAGR of 6.77% during the forecast period of 2024 to 2032.
The estimated market value of the China Swine Vaccines Market for final year is USD 812.45 (USD Million).
HAVE A QUESTION?
Get expert advice on the right strategy for your business at no cost. We also offer customized subscription plans and affordable discounts for startups and universities.